Journal article
Real-world effectiveness of repeated ketamine infusions for treatment resistant depression during the COVID-19 pandemic
Abstract
Herein we evaluate the impact of COVID-19 restrictions on antidepressant effectiveness of intravenous (IV) ketamine in adults with treatment-resistant depression (TRD). We conducted a case series analysis of adults with TRD (n = 267) who received four ketamine infusions at an outpatient clinic in Ontario, Canada, during COVID-19 restrictions (from March 2020 - February 2021; n = 107), compared to patients who received treatment in the previous …
Authors
Rosenblat JD; Lipsitz O; Di Vincenzo JD; Rodrigues NB; Kratiuk K; Subramaniapillai M; Lee Y; Arekapudi AK; Abrishami A; Chau EH
Journal
Psychiatry Research, Vol. 303, ,
Publisher
Elsevier
Publication Date
September 2021
DOI
10.1016/j.psychres.2021.114086
ISSN
0165-1781